TORONTO, Feb. 8, 2024
/CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (the
"Trust") announces that it will hold a conference call to discuss
its fourth quarter and full year 2023 financial results on
Thursday, February 29, 2024, at
8:00 a.m. ET. The Trust will report
its financial results on Wednesday, February
28, 2024, after market close.
All interested parties may join the conference call by dialing
416-764-8659 or 1-888-664-6392 approximately 15 minutes prior to
the call to secure a line. Participants will be put on hold until
the conference call begins. A question-and-answer session will
follow management's prepared remarks, at which time the operator
will provide instructions for qualified equity analysts to submit
questions.
A live webcast of the conference call, including a slide
presentation, will be available at
https://app.webinar.net/09MwQ3j7DLE. Please connect at least 15
minutes prior to the conference call to ensure adequate time for
any software download that may be required to join the webcast. The
webcast will be archived on the Trust's website following the call
date.
About DRI Healthcare
Trust
DRI Healthcare Trust is managed by DRI Capital Inc. ("DRI
Capital"), the pioneer in global pharmaceutical royalty
monetization with a more than 30-year history
of accelerating innovation by providing capital
to inventors, academic institutions and biopharma
companies. Since its founding in 1989, DRI Capital has deployed
more than US$3.0
billion, acquiring more than 70 royalties on 45-plus drugs,
including Eylea, Keytruda, Orserdu,
Spinraza, Stelara, Vonjo, Zejula and Zytiga. DRI Healthcare
Trust's units are listed and trade on the Toronto Stock Exchange in
Canadian dollars under the symbol "DHT.UN"
and in U.S. dollars under the symbol
"DHT.U". To learn more, visit
drihealthcare.com or follow us on LinkedIn.
SOURCE DRI Healthcare Trust
